Barclays
ATRC icon

Barclays’s AtriCure ATRC Stock Holding History

Barclays’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-95,700
Closed -$3.82M – 4862
2020
Q3 		$3.82M Buy
95,700
+92,700
+3,090% +$3.93M ﹤0.01% 1585
2020
Q2 		$135K Hold
3,000
– – ﹤0.01% 4336
2020
Q1 		$101K Buy
+3,000
New +$108K ﹤0.01% 4785

Other funds holding ATRC

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barclays's ATRC Position: Q1 2026 in Review

Barclays reduced its AtriCure (ATRC) stake by 80% in Q1 2026, selling an estimated $2.54M and leaving 18,135 shares worth $517K. The position accounts for ﹤0.01% of the portfolio, ranked #3171.

Barclays first reported a position in ATRC in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.44M in Q1 2020. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

  • Barclays held 18,135 shares of AtriCure worth $517K as of Q1 2026.
  • Barclays sold 74,471 AtriCure shares in Q1 2026, an estimated $2.54M.
  • AtriCure made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3171 holding.
  • Barclays first reported a position in AtriCure in Q2 2013 and has held it in 52 quarters since.
  • Barclays's AtriCure position peaked at $7.44M in Q1 2020.
  • 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.